CorporateSun Pharma Recalls Select Eye Drops, Asks Distributors to Stop Sales as Precautionary MeasureBY Outlook Business Desk
CorporateSun Pharma Q1 Profit Climbs 27% YoY to ₹2,895 Cr Despite Weak US Generics BusinessBY Outlook Business Desk
CorporateOrganon Shareholders Approve Sun Pharma Merger, Deal Nears CompletionBY Outlook Business Desk
CorporateSBI Set to Join Global Lenders in Funding Sun Pharma’s $12 Bn Organon AcquisitionBY Outlook Business Desk
CorporateSun Pharma Q4FY26 Cons Net Profit Jumps 26% YoY; Board Declares ₹5 DividendBY Outlook Business Desk
CorporateSun Pharma–Organon Deal: Where Does It Rank in the List of Outgoing Acquisitions?BY Outlook Business Desk
CorporateNovo Nordisk Cuts Ozempic, Wegovy Prices by Up to 48% Amid Generic PressureBY Outlook Business Desk
CorporateSun Pharma Partners With Royal Challengers Bengaluru As Principal Sponsor For 3-Year PeriodBY PTI
